Search Results 241-250 of 11773 for ���������������������������:za33���24������ ������������������������ ������

  1. A Study of Momelotinib Versus Danazol in Symptomatic and Anemic Myelofibrosis Patients - Mayo Clinic

    Subjects randomized to receive DAN who are receiving clinical benefit at the end of Week 24 may choose to continue DAN therapy up to Week 48. The comparator ...

  2. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  3. Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy - Mayo Clinic

    Scottsdale/Phoenix, Arizona: 24-013595; Jacksonville, Florida: 24-013595. NCT ID: NCT06604442. Sponsor Protocol Number: BED-PSMA-411. About this study. The ...

  4. CV/CV Surgery Booklet - MC5751-10

    livered to the individual sites within 24 hours. Studies done on the Mayo Clinic Rochester campus are reviewed by a staff echocardiographer before the ...

  5. A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors (SPX-303) - Mayo Clinic

    Jacksonville, Florida: 24-004302; Rochester, Minnesota: 24-004302; Scottsdale/Phoenix, Arizona: 24-004302. NCT ID: NCT06259552. Sponsor Protocol Number: PROT-CR ...

  6. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  7. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  8. Clinical Trials - A Study of the BeWell360-CPR

    Jacksonville, Florida: 24-009660. About this study. The purpose of this study is to enhance and optimize the BeWell360-CPR digital health app. Participation ...

  9. A Study To Investigate The Efficacy, Safety, And Pharmacokinetics Of Oral Rilzabrutinib Compared With Placebo In Participants 18 Years Of Age And Older With Warm Autoimmune Hemolytic Anemia - Mayo Clinic

    ... 24 weeks. All participants who completed PAP will then continue in open-label period (OLP) to receive rilzabrutinib for a duration of 28 weeks. Upon the ...

  10. Alzheimer’s Disease Research Centers (ADRC) Consortium for ADRD Research Through Imaging Clarity - Mayo Clinic

    Rochester, Minnesota: 24-001093. About this study. The purpose of this study is to create a foundational resource for conducting and sharing ATN imaging and ...